These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 32162746)

  • 1. Ursodeoxycholyl lysophosphatidylethanolamide protects against hepatic ischemia/reperfusion injury via phospholipid metabolism-mediated mitochondrial quality control.
    Gu J; Zhang T; Guo J; Chen K; Wang G; Li H; Wang J
    FASEB J; 2020 May; 34(5):6198-6214. PubMed ID: 32162746
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ursodeoxycholyl lysophosphatidylethanolamide protects against hepatic ischemia and reperfusion injury in mice.
    Wang J; Deng X; Yi S; Pathil A; Zhang W; Setchell K; Stremmel W; Chamulitrat W
    Shock; 2015 Apr; 43(4):379-86. PubMed ID: 25526375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The synthetic bile acid-phospholipid conjugate ursodeoxycholyl lysophosphatidylethanolamide suppresses TNFα-induced liver injury.
    Pathil A; Warth A; Chamulitrat W; Stremmel W
    J Hepatol; 2011 Apr; 54(4):674-84. PubMed ID: 21146893
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ursodeoxycholyl Lysophosphatidylethanolamide modifies aberrant lipid profiles in NAFLD.
    Pathil A; Liebisch G; Okun JG; Chamulitrat W; Schmitz G; Stremmel W
    Eur J Clin Invest; 2015 Sep; 45(9):925-31. PubMed ID: 26108973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bile salt-phospholipid conjugate ursodeoxycholyl lysophosphatidylethanolamide as a hepatoprotective agent.
    Chamulitrat W; Burhenne J; Rehlen T; Pathil A; Stremmel W
    Hepatology; 2009 Jul; 50(1):143-54. PubMed ID: 19496180
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-inflammatory properties of ursodeoxycholyl lysophosphatidylethanolamide in endotoxin-mediated inflammatory liver injury.
    Ludwig JM; Zhang Y; Chamulitrat W; Stremmel W; Pathil A
    PLoS One; 2018; 13(5):e0197836. PubMed ID: 29795632
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ursodeoxycholyl lysophosphatidylethanolamide inhibits lipoapoptosis by shifting fatty acid pools toward monosaturated and polyunsaturated fatty acids in mouse hepatocytes.
    Chamulitrat W; Liebisch G; Xu W; Gan-Schreier H; Pathil A; Schmitz G; Stremmel W
    Mol Pharmacol; 2013 Nov; 84(5):696-709. PubMed ID: 23974795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Bile Acid-Phospholipid Conjugate Ursodeoxycholyl-Lysophosphatidylethanolamide (UDCA-LPE) Disintegrates the Lipid Backbone of Raft Plasma Membrane Domains by the Removal of the Membrane Phospholipase A2.
    Stremmel W; Staffer S; Fricker G; Weiskirchen R
    Int J Mol Sci; 2019 Nov; 20(22):. PubMed ID: 31717968
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oleic Acid Protects against Hepatic Ischemia and Reperfusion Injury in Mice by Inhibiting AKT/mTOR Pathways.
    Guo J; Zhang T; Gu J; Cai K; Deng X; Chen K; Huang K; Wang G; Li H; Wang J
    Oxid Med Cell Longev; 2019; 2019():4842592. PubMed ID: 31915509
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of different bile acid-phospholipid conjugates in acute hepatitis.
    Pathil A; Warth A; Chamulitrat W; Stremmel W
    Eur J Clin Invest; 2012 Feb; 42(2):130-8. PubMed ID: 21707612
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ursodeoxycholyl lysophosphatidylethanolamide improves steatosis and inflammation in murine models of nonalcoholic fatty liver disease.
    Pathil A; Mueller J; Warth A; Chamulitrat W; Stremmel W
    Hepatology; 2012 May; 55(5):1369-78. PubMed ID: 22183915
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ursodeoxycholyl lysophosphatidylethanolamide attenuates hepatofibrogenesis by impairment of TGF-β1/Smad2/3 signalling.
    Pathil A; Mueller J; Ludwig JM; Wang J; Warth A; Chamulitrat W; Stremmel W
    Br J Pharmacol; 2014 Nov; 171(22):5113-26. PubMed ID: 25041068
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ursodeoxycholyl Lysophosphatidylethanolamide Protects Against CD95/FAS-Induced Fulminant Hepatitis.
    Utaipan T; Otto AC; Gan-Schreier H; Chunglok W; Pathil A; Stremmel W; Chamulitrat W
    Shock; 2017 Aug; 48(2):251-259. PubMed ID: 28060213
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bivalent Ligand UDCA-LPE Inhibits Pro-Fibrogenic Integrin Signalling by Inducing Lipid Raft-Mediated Internalization.
    Su J; Gan-Schreier H; Goeppert B; Chamulitrat W; Stremmel W; Pathil A
    Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30347788
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ursodeoxycholyl lysophosphatidylethanolamide negatively regulates TLR-mediated lipopolysaccharide response in human THP-1-derived macrophages.
    Horvatova A; Utaipan T; Otto AC; Zhang Y; Gan-Schreier H; Pavek P; Pathil A; Stremmel W; Chamulitrat W
    Eur J Pharmacol; 2018 Apr; 825():63-74. PubMed ID: 29475064
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brusatol Protects HepG2 Cells against Oxygen-Glucose Deprivation-Induced Injury via Inhibiting Mitochondrial Reactive Oxygen Species-Induced Oxidative Stress.
    Zhu S; Liu S; Wang L; Ding W; Sha J; Qian H; Lu Y
    Pharmacology; 2020; 105(7-8):416-423. PubMed ID: 31825932
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatoprotectant ursodeoxycholyl lysophosphatidylethanolamide increasing phosphatidylcholine levels as a potential therapy of acute liver injury.
    Chamulitrat W; Zhang W; Xu W; Pathil A; Setchell K; Stremmel W
    Front Physiol; 2012; 3():24. PubMed ID: 22363296
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sirtuin 1 Stimulation Attenuates Ischemic Liver Injury and Enhances Mitochondrial Recovery and Autophagy.
    Khader A; Yang WL; Godwin A; Prince JM; Nicastro JM; Coppa GF; Wang P
    Crit Care Med; 2016 Aug; 44(8):e651-63. PubMed ID: 26963320
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PINK1 Activation and Translocation to Mitochondria-Associated Membranes Mediates Mitophagy and Protects Against Hepatic Ischemia/Reperfusion Injury.
    Gu J; Zhang T; Guo J; Chen K; Li H; Wang J
    Shock; 2020 Dec; 54(6):783-793. PubMed ID: 32195921
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cilostazol attenuates murine hepatic ischemia and reperfusion injury via heme oxygenase-dependent activation of mitochondrial biogenesis.
    Joe Y; Zheng M; Kim HJ; Uddin MJ; Kim SK; Chen Y; Park J; Cho GJ; Ryter SW; Chung HT
    Am J Physiol Gastrointest Liver Physiol; 2015 Jul; 309(1):G21-9. PubMed ID: 25951827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.